IBDEI0NJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10474,1,4,0)
 ;;=4^H26.109
 ;;^UTILITY(U,$J,358.3,10474,2)
 ;;=^5133478
 ;;^UTILITY(U,$J,358.3,10475,0)
 ;;=H20.00^^74^681^1
 ;;^UTILITY(U,$J,358.3,10475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10475,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute NEC
 ;;^UTILITY(U,$J,358.3,10475,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,10475,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,10476,0)
 ;;=H20.051^^74^681^12
 ;;^UTILITY(U,$J,358.3,10476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10476,1,3,0)
 ;;=3^Hypopyon,Right Eye
 ;;^UTILITY(U,$J,358.3,10476,1,4,0)
 ;;=4^H20.051
 ;;^UTILITY(U,$J,358.3,10476,2)
 ;;=^5005150
 ;;^UTILITY(U,$J,358.3,10477,0)
 ;;=H20.052^^74^681^13
 ;;^UTILITY(U,$J,358.3,10477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10477,1,3,0)
 ;;=3^Hypopyon,Left Eye
 ;;^UTILITY(U,$J,358.3,10477,1,4,0)
 ;;=4^H20.052
 ;;^UTILITY(U,$J,358.3,10477,2)
 ;;=^5005151
 ;;^UTILITY(U,$J,358.3,10478,0)
 ;;=B00.52^^74^681^6
 ;;^UTILITY(U,$J,358.3,10478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10478,1,3,0)
 ;;=3^Herpes Viral Keratitis
 ;;^UTILITY(U,$J,358.3,10478,1,4,0)
 ;;=4^B00.52
 ;;^UTILITY(U,$J,358.3,10478,2)
 ;;=^5000474
 ;;^UTILITY(U,$J,358.3,10479,0)
 ;;=B00.51^^74^681^7
 ;;^UTILITY(U,$J,358.3,10479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10479,1,3,0)
 ;;=3^Herpes Viral Iridocyclitis
 ;;^UTILITY(U,$J,358.3,10479,1,4,0)
 ;;=4^B00.51
 ;;^UTILITY(U,$J,358.3,10479,2)
 ;;=^5000473
 ;;^UTILITY(U,$J,358.3,10480,0)
 ;;=B00.59^^74^681^8
 ;;^UTILITY(U,$J,358.3,10480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10480,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,10480,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,10480,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,10481,0)
 ;;=B02.33^^74^681^9
 ;;^UTILITY(U,$J,358.3,10481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10481,1,3,0)
 ;;=3^Herpes Zoster Keratitis
 ;;^UTILITY(U,$J,358.3,10481,1,4,0)
 ;;=4^B02.33
 ;;^UTILITY(U,$J,358.3,10481,2)
 ;;=^5000496
 ;;^UTILITY(U,$J,358.3,10482,0)
 ;;=B02.32^^74^681^10
 ;;^UTILITY(U,$J,358.3,10482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10482,1,3,0)
 ;;=3^Herpes Zoster Iridocyclitis
 ;;^UTILITY(U,$J,358.3,10482,1,4,0)
 ;;=4^B02.32
 ;;^UTILITY(U,$J,358.3,10482,2)
 ;;=^5000495
 ;;^UTILITY(U,$J,358.3,10483,0)
 ;;=B02.39^^74^681^11
 ;;^UTILITY(U,$J,358.3,10483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10483,1,3,0)
 ;;=3^Herpes Zoster Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,10483,1,4,0)
 ;;=4^B02.39
 ;;^UTILITY(U,$J,358.3,10483,2)
 ;;=^5000498
 ;;^UTILITY(U,$J,358.3,10484,0)
 ;;=H21.01^^74^681^14
 ;;^UTILITY(U,$J,358.3,10484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10484,1,3,0)
 ;;=3^Hyphema,Right Eye
 ;;^UTILITY(U,$J,358.3,10484,1,4,0)
 ;;=4^H21.01
 ;;^UTILITY(U,$J,358.3,10484,2)
 ;;=^5005172
 ;;^UTILITY(U,$J,358.3,10485,0)
 ;;=H21.02^^74^681^15
 ;;^UTILITY(U,$J,358.3,10485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10485,1,3,0)
 ;;=3^Hyphema,Left Eye
 ;;^UTILITY(U,$J,358.3,10485,1,4,0)
 ;;=4^H21.02
 ;;^UTILITY(U,$J,358.3,10485,2)
 ;;=^5005173
 ;;^UTILITY(U,$J,358.3,10486,0)
 ;;=H44.001^^74^681^24
 ;;^UTILITY(U,$J,358.3,10486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10486,1,3,0)
 ;;=3^Purulent Endophthalmitis,Right Eye
 ;;^UTILITY(U,$J,358.3,10486,1,4,0)
 ;;=4^H44.001
 ;;^UTILITY(U,$J,358.3,10486,2)
 ;;=^5005963
 ;;^UTILITY(U,$J,358.3,10487,0)
 ;;=H44.002^^74^681^25
 ;;^UTILITY(U,$J,358.3,10487,1,0)
 ;;=^358.31IA^4^2
